ASCT2 is the primary serine transporter in cancer cells
Conger, K. O.; Chidley, C.; Ozgurses, M. E.; Zhao, H.; Kim, Y.; Semina, S. E.; Burns, P. A.; Rawat, V.; Sheldon, R.; Ben-Sahra, I.; Frasor, J.; Sorger, P. K.; DeNicola, G. M.; Coloff, J. L.
Show abstract
The non-essential amino acid serine is a critical nutrient for cancer cells due to its diverse biosynthetic functions. While some tumors can synthesize serine de novo, others are auxotrophic for serine and therefore reliant on the uptake of exogenous serine. Importantly, however, the transporter(s) that mediate serine uptake in cancer cells are not known. Here, we characterize the amino acid transporter ASCT2 (coded for by the gene SLC1A5) as the primary serine transporter in cancer cells. ASCT2 is well-known as a glutamine transporter in cancer, and our work demonstrates that serine and glutamine compete for uptake through ASCT2. We further show that ASCT2-mediated serine uptake is essential for purine nucleotide biosynthesis and that ER promotes serine uptake by directly activating SLC1A5 transcription. Together, our work defines an additional important role for ASCT2 as a serine transporter in cancer and evaluates ASCT2 as a potential therapeutic target in serine metabolism.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Metabolic regulation of RNA methylation by the m6A-reader IGF2BP3 95%
- Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control 95%
- Target deconvolution of an insulin hypersecretion-inducer acting through VDAC1 with a distinct transcriptomic signature in beta-cells 95%
Similar papers in this journal
Similar papers in this journal
- Signal peptide-independent secretion of keratin-19 by pancreatic cancer cells 95%
- Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1 95%
- CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors. 95%
Similar papers in this journal
- Glucose deprivation promotes pseudo-hypoxia and de-differentiation in lung adenocarcinoma 94%
- EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes 94%
- PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.